These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26735018)

  • 41. Targeting DYRK1A/B kinases to modulate p21-cyclin D1-p27 signalling and induce anti-tumour activity in a model of human glioblastoma.
    Massey AJ; Benwell K; Burbridge M; Kotschy A; Walmsley DL
    J Cell Mol Med; 2021 Nov; 25(22):10650-10662. PubMed ID: 34708541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis.
    Liu XD; Yao J; Tripathi DN; Ding Z; Xu Y; Sun M; Zhang J; Bai S; German P; Hoang A; Zhou L; Jonasch D; Zhang X; Conti CJ; Efstathiou E; Tannir NM; Eissa NT; Mills GB; Walker CL; Jonasch E
    Oncogene; 2015 May; 34(19):2450-60. PubMed ID: 24998849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic and pharmacological strategies to refunctionalize the von Hippel Lindau R167Q mutant protein.
    Ding Z; German P; Bai S; Reddy AS; Liu XD; Sun M; Zhou L; Chen X; Zhao X; Wu C; Zhang S; Mills GB; Jonasch E
    Cancer Res; 2014 Jun; 74(11):3127-36. PubMed ID: 24755468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor α.
    Okumura F; Uematsu K; Byrne SD; Hirano M; Joo-Okumura A; Nishikimi A; Shuin T; Fukui Y; Nakatsukasa K; Kamura T
    Mol Cell Biol; 2016 Jun; 36(12):1803-17. PubMed ID: 27090638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma.
    Martin CE; Nguyen A; Kang MK; Kim RH; Park NH; Shin KH
    Exp Cell Res; 2021 Aug; 405(1):112656. PubMed ID: 34033760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. von Hippel-Lindau-dependent patterns of RNA polymerase II hydroxylation in human renal clear cell carcinomas.
    Yi Y; Mikhaylova O; Mamedova A; Bastola P; Biesiada J; Alshaikh E; Levin L; Sheridan RM; Meller J; Czyzyk-Krzeska MF
    Clin Cancer Res; 2010 Nov; 16(21):5142-52. PubMed ID: 20978146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emetine promotes von Hippel-Lindau-independent degradation of hypoxia-inducible factor-2α in clear cell renal carcinoma.
    Kong HS; Lee S; Beebe K; Scroggins B; Gupta G; Lee MJ; Jung YJ; Trepel J; Neckers L
    Mol Pharmacol; 2010 Dec; 78(6):1072-8. PubMed ID: 20813864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ID2-ETS2 axis regulates the transcriptional acquisition of pro-tumoral microglia phenotype in glioma.
    Vázquez-Cabrera G; Škandík M; Roncier N; Real Oualit F; Cruz De Los Santos M; Baleviciute A; Cheray M; Joseph B
    Cell Death Dis; 2024 Jul; 15(7):512. PubMed ID: 39019900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. USP37 promotes deubiquitination of HIF2α in kidney cancer.
    Hong K; Hu L; Liu X; Simon JM; Ptacek TS; Zheng X; Liao C; Baldwin AS; Zhang Q
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13023-13032. PubMed ID: 32461361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma.
    Ordóñez-Navadijo Á; Fuertes-Yebra E; Acosta-Iborra B; Balsa E; Elorza A; Aragonés J; Landazuri MO
    Oncogene; 2016 Feb; 35(5):587-94. PubMed ID: 25915846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. pVHL mediates K63-linked ubiquitination of IKKβ, leading to IKKβ inactivation.
    Wang Y; Zhao W; Gao Q; Fan L; Qin Y; Zhou H; Li M; Fang J
    Cancer Lett; 2016 Dec; 383(1):1-8. PubMed ID: 27693634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma.
    Turcotte S; Desrosiers RR; Beliveau R
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F338-48. PubMed ID: 14583436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. von Hippel-Lindau protein promotes Skp2 destabilization on DNA damage.
    Roe JS; Kim HR; Hwang IY; Cho EJ; Youn HD
    Oncogene; 2011 Jul; 30(28):3127-38. PubMed ID: 21358672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy.
    Kwak JH; Lee NH; Lee HY; Hong IS; Nam JS
    Oncotarget; 2016 Jul; 7(28):43518-43533. PubMed ID: 27270657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction between Mnk2 and CBC(VHL) ubiquitin ligase E3 complex.
    Wang P; Wang X; Wang F; Cai T; Luo Y
    Sci China C Life Sci; 2006 Jun; 49(3):265-73. PubMed ID: 16856496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR.
    Zhou L; Yang H
    PLoS One; 2011; 6(9):e23936. PubMed ID: 21949687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer.
    Kaelin WG
    Trans Am Clin Climatol Assoc; 2017; 128():298-307. PubMed ID: 28790514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway.
    Ivanova AV; Ivanov SV; Danilkovitch-Miagkova A; Lerman MI
    J Biol Chem; 2001 May; 276(18):15306-15. PubMed ID: 11278694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.
    Schöning JP; Monteiro M; Gu W
    Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):153-161. PubMed ID: 27809360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.